Therapeutic areas in focus
Pharmafile is excited to announce the launch of our brand new website, where you can find everything Pharmafile!
In any industry, companies must innovate and collaborate in order to drive their growth and success, and in the life sciences industry this is now more important than ever.
Pharmafile is distributed to over 20,000 life science professionals and sponsors a number of international trade events throughout the year, enabling advertisers to reach a wide audience.
Take advantage of Samedan’s e-marketing service to send targeted emails to more than 50,000 digital subscribers.
This issue includes the latest news, as well as articles on Cardiovascular and Metabolic Diseases, Women's Health, and Oncology.
Welcome to the autumn 2023 issue of Pharmafile! As the summer draws to a close, it is an ideal time to consider 2023 so far and where it might take us in the remaining months.
Welcome to the Autumn 2023 issue of Pharmafile!
Pfizer has announced that the CDC Advisory Committee on Immunization Practices (ACIP) has recommended the company’s bivalent respiratory syncytial virus (RSV) vaccine, Abrysvo, for maternal immunisation.